DEUTSCHE BANK AG\
BankPosition in VYGR — Voyager Therapeutics, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in VYGR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$179,525
+$25,010 QoQ
Shares Held
51,293
+28.1% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 135 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. VYGR ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in VYGR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $179,525 | 51,293 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $154,515 | 40,030 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $124,459 | 31,669 | Shares | Defined | 2026-02-11 | |
| 2025-06-30 | $82,178 | 26,424 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $123,511 | 36,542 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $240,804 | 42,470 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $458,452 | 78,368 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $558,825 | 70,648 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $669,453 | 71,907 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $555,233 | 65,786 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $502,448 | 64,832 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $778,325 | 67,976 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $414,027 | 53,700 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $335,500 | 55,000 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $325,600 | 55,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $325,050 | 55,000 | Shares | Defined | 2022-08-11 | |
| 2021-06-30 | $2,606 | 631 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $128,054 | 27,188 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $369,053 | 51,616 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $885,586 | 82,998 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $654,244 | 51,842 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $86,264 | 9,428 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||